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ORIGINAL ARTICLE

Effects of Hypoxic and Ischemic Clinical Conditions on the
Outcomes of Acute Ischemic Stroke Patients
Umeshkumar Athiraman1, Rene Tempelhoff2, Menelaos Karanikolas3

A b s t r ac t
Background: Several studies have shown the neuroprotective role afforded by hypoxic and ischemic preconditioning in cerebrovascular
disorders. There are several clinical conditions which simulate the hypoxic and ischemic conditioning in humans. The aim of this retrospective
study is to identify whether the presence of any clinical scenarios mimicking the hypoxic and ischemic conditions prior to the current acute
ischemic stroke (AIS) has a neuroprotective role in these patients.
Materials and methods: Data were collected for patients >18 years of age who underwent endovascular treatment for AIS from January
2009 to June 2015. A good outcome was defined as modified Rankin score (mRS) of 0 to 3 at discharge and a poor outcome as mRS of 4–6.
A logistic regression analysis was performed to identify independent predictors of outcomes at discharge in both groups. A p value of <0.05
was considered statistically significant for all analyses.
Results: A total of 102 patients, aged 67 ± 16 years with median preprocedural National Institute of Health Stroke Scale (NIHSS) score 17.5 (1–36),
were included. Twenty-one (21%) patients had a good outcome (mRS: 0–3) and 81 (79%) had a poor outcome (mRS: 4–6). A logistic regression
analysis identified higher NIHSS score [odds ratio (OR): 1.251, confidence interval (CI): 1.11–1.40, p = 0.0002] and history of transient ischemic
attack (TIA; OR: 7.881, CI: 1.05–21.01, p < 0.04) as predictors of a poor outcome at discharge.
Conclusion: Our data suggest that the occurrence of TIA preceding an AIS may be associated with the poor outcomes in patients with AIS,
although this finding needs confirmation in larger studies.
Keywords: Acute ischemic stroke, Hypoxic conditioning, Ischemic conditioning.
Indian Journal of Critical Care Medicine (2020): 10.5005/jp-journals-10071-23349

I n t r o d u c t i o n
Conditioning is a strategy where a sublethal noxious stimulus
presented to any tissue in the body invokes endogenous protective
mechanisms so that the organ develops tolerance toward
subsequent similar or stronger insult. A variety of conditioning
agents have been shown to provide protection in a variety of
organ systems through conditioning-based mechanisms.1–3
Although initially applied for cardiac protection, this application
has been shown to elicit therapeutic benefits for various organ
systems such as brain, liver, kidney, lung, pancreas, skin, skeletal
and smooth muscle, and the peripheral vasculature.4 Conditioning
against brain injury can be induced by various conditions and
agents such as ischemia,4–7 hypoxia,6–9 anesthetics,3 thrombin,2
lipopolysaccharides,1 and many drugs some of which have already
been approved by Food and Drug Administration.
Hypoxia and ischemia are the two most commonly studied
conditioned stimuli in various central nervous system pathologies,
and there are several animal and clinical studies which have shown
the neuroprotective role of hypoxic and ischemic preconditioning
in acute ischemic stroke (AIS).4–9 Certain clinical comorbidities, such
as chronic obstructive pulmonary disease (COPD), obstructive sleep
apnea (OSA),10,11 TIA,12–15 and peripheral vascular disease (PVD)16
may simulate the hypoxic and ischemic preconditioning state.
The aim of our study is to assess the neurovascular protective role
of various clinical scenarios which imitate hypoxic and ischemic
conditions in patients who presented with AIS.

M at e r ia l s

a n d  M e t h o d s

After institutional review board approval, data were collected
from all patients >18 years of age who underwent endovascular
treatment of AIS at our comprehensive stroke center from January
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2009 to June 2015. A total of 106 patients were treated during the
study period. Out of 106, 102 patients had conscious sedation and
4 patients had general anesthesia. Patients treated under general
anesthesia were excluded. Data on comorbid diseases, medication
history, laboratory parameters, and social history were collected
from electronic medical records. The NIHSS score and the mRS at
discharge and at 3 months were obtained from the Department of
Neurology database. The NIHSS score was evaluated by vascular
neurology residents and fellows, and the mRS score was evaluated
by stroke nurses certified in the use of the mRS instrument. The
primary outcome measure is the mRS at discharge. A good outcome
is defined as mRS of 0–3 and a poor outcome as mRS of 4–6.

Statistical Analysis
The clinical conditions of patients with a good outcome were
compared with those of patients with a poor outcome using
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the univariate analysis with Chi-square test, Fisher’s exact test,
independent t test, and Mann–Whitney test, as appropriate.
Variables which are not normally distributed are represented
as median (minimum, maximum). A logistic regression analysis
was performed with a neurologic outcome at discharge as the
dependent variable, using the ENTER method, to evaluate factors
of interest (age, history of TIA, and pre-procedural NIHSS score)
as independent predictors of a poor outcome at discharge. The
overall fit of the regression model was assessed using the c-statistic,
measuring the area under the receiver-operating characteristic
(ROC) curve (AUC) and with Hosmer and Lemeshow test as a
measure of goodness of fit. Statistical analyses were performed
using MedCalc for Windows, version 18.11 (MedCalc Software,
Ostend, Belgium). A p value of <0.05 was considered statistically
significant for all analyses.

R e s u lts
A total of 102 patients (81 men and 21 women), aged 67 ± 16 years,
were included. The anterior cerebral circulation was affected in 88
patients (86%), and the median preprocedural NIHSS score was 17.5
(1–36). Overall, 21 (21%) patients had a good outcome (mRS: 0–3),
and 81 (79%) had a poor outcome (mRS: 4–6).
Table 1 shows the various clinical conditions for patients with
a good outcome vs patients with a poor outcome at discharge.
In this series, patients with the good outcomes had significantly

lower NIHSS score (p ≤ 0.0001) and lower incidence of TIA prior to
the current stroke (p = 0.007). There was no significant difference
between the two groups with respect to age, gender, hypertension,
atrial fibrillation, diabetes, renal insufficiency, anemia, coronary
artery disease, congestive heart failure, valvular problems,
OSA, COPD, thyroid problems, pulmonary embolism, deep vein
thrombosis, cancer history, smoking, alcohol, drug abuse, and use
of medications.
Table 2 shows the subgroup analysis between patients with
and without TIA. Significant differences between patients with
and without TIA were found for the following variables: NIHSS
score at the presentation (p = 0.037), history of stroke (p ≤
0.0001), hyperlipidemia (p = 0.002), hypertension (p < 0.0001),
cardiomyopathy (p = 0.005), and hypothyroidism (p = 0.03).
No significant differences were noted between the two groups
for the variables age, gender, atrial fibrillation, diabetes, renal
insufficiency, anemia, coronary artery disease, congestive heart
failure, valvular problems, OSA, COPD, pulmonary embolism, deep
vein thrombosis, cancer history, smoking, alcohol, drug abuse, and
use of medications.
Table 3 shows the results of the logistic regression analysis
done to identify independent factors predicting a poor outcome
at discharge. The final multivariable logistic regression model had
very good discrimination (c-statistic of 0.85) and good calibration
(Hosmer–Lemeshow test, Chi-square = 7.47, p = 0.48) with overall

Table 1: Comparison of clinical characteristics in patients with good vs poor outcomes based on modified
Rankin score
Variable
Age
Sex (F/M)
Hematocrit
Preprocedural NIHSS score
History of stroke
History of TIA
Hypertension
A-fib
Diabetes
Renal insufficiency
Anemia
COPD
Drug abuse
Alcohol use
Tobacco use
Coronary disease
Myocardial infarction
Valve disease
CHF
Cardiomyopathy
Hypothyroidism
PVD
DVT
PE
OSA

Good outcome
(mRS: 0–3), n = 21
70 (38, 86)
13/8
36.6 (25, 46)
13 (1, 23)
3
3
13
6
6
3
13
2
2
5
5
6
1
2
3
2
1
0
0
0
1

Poor outcome
(mRS: 4–6), n = 81
70 (19, 90)
45/36
37 (19, 49)
20 (8, 36)
16
38
65
28
25
15
47
12
8
23
34
24
6
9
17
13
13
3
3
2
7

p value
0.719
0.601
0.331
<0.0001
0.413
0.007
0.077
0.603
0.839
0.650
0.747
0.413
0.662
0.675
0.127
0.924
0.669
0.834
0.491
0.452
0.163
0.497
0.497
0.629
0.480

Data are presented as median (minimum, maximum) or frequency as appropriate; p < 0.05 is statistically significant;
CHF, congestive heart failure; DVT, deep venous thrombosis; PE, pulmonary embolism; A-fib, atrial fibrillation
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Table 2: Comparison of patients with vs without history of transient ischemic attack
Patients without
TIA (n = 61)
66.7 ± 16.5
26/35
36.2 ± 6.9
16 (7, 35)
3
23
39
19
15
9
35
9
8
18
3
24
13
3
6
10
4
12
2
3
1

Variable
Age
Men/women
Hematocrit
Preprocedural NIHSS score
History of stroke
HLD
Hypertension
A-fib
Diabetes
Renal insufficiency
Anemia
COPD
Drug abuse
Alcohol use
OSA
Tobacco use
Coronary disease
MI
Valve disease
CHF
Cardiomyopathy
Hypothyroidism
PVD
DVT
PE

Patients with
TIA (n = 41)
66.7 ± 15.4
18/23
36.4 ± 5.8
20 (1, 36)
16
28
39
15
16
9
25
5
2
10
5
15
17
4
5
10
11
2
1
0
1

p value
0.997
1.000
0.882
0.037
<0.0001
0.002
<0.0001
0.568
0.120
0.350
0.717
0.713
0.308
0.570
0.180
0.779
0.029
0.343
0.706
0.319
0.005
0.033
0.806
0.149
1.000

Data are summarized as mean ± standard deviation, median (minimum, maximum) or number of cases. Variables were
compared between groups using Student’s t test, Mann–Whitney, Chi-square, or Fisher’s exact test as appropriate;
CHF, congestive heart failure; DVT, deep venous thrombosis; PE, pulmonary embolism; MI, myocardial infarction;
HLD, hyperlipidemia; A-fib, atrial fibrillation

Table 3: Logistic regression anal ysis to evaluate predictors of a poor
outcome at discharge
Variable
Age
History of TIA
Preprocedural NIHSS score

p value
0.48
0.04
0.0002

OR
0.98
4.70
1.25

95% CI
0.95–1.02
1.05–21.01
1.11–1.40

Values are represented as OR and 95% CI; p < 0.05 is statistically significant

AUC 0.85 (Fig. 1). The NIHSS score (OR: 1.25, CI: 1.11–1.40, p = 0.0002)
and previous TIA (OR: 4.70, CI: 1.05–21.01, p = 0.04) were shown to
be significant predictors of a poor outcome at discharge.

D i s c u s s i o n
The main finding in our study is that the patients with history of
previous TIA and subsequent AIS have poor prognosis compared
with patients without history of TIA. This finding contradicts the
findings of several clinical and animal studies where TIA was shown
to confer neurovascular protection, presumably due to ischemic
preconditioning, although controversial evidence exists related
to the history of previous TIA and the outcomes of consequent
AIS.12–25 Ischemic stroke is one of the common reasons for mortality
and morbidity throughout the world, and it is well known that the
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Fig. 1: Receiver operating characteristic curve for the predictor variables
and the entire model. Area under the curve for the overall model is 0.851

occurrence of TIA increases the risk of consecutive ischemic stroke.26
Knowledge regarding the effects of TIA on the subsequent attack
of the ischemic stroke is critical as therapies can be effectively used
to prevent the recurrent stroke.
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Ischemic conditioning is a commonly applied powerful strategy
which is shown to have strong protective effects in various organs,
including the brain. 27 Ischemic conditioning not only provides
neuronal protection but also protection against other components
of the neurovascular network such as glia and vascular endothelial
cells. 27 The neuroprotection through ischemic conditioning is
proposed to occur through multiple mechanisms such as (1)
depression of cerebral metabolism and activity, (2) activation of
signaling pathways and mechanisms at the cellular level, (3) changes
in mitochondrial functions, and (4) alterations of excitatory and
inhibitory neurotransmitters and other processes.27
Clinical conditions such as TIA, COPD, OSA, and PVD may
result in a naturally occurring ischemic preconditioning process.
Obstructive sleep apnea is a disease condition where patients
are exposed to repeated short episodes of hypoxemia through
multiple apneic episodes during sleep. The intermittent hypoxia
caused by these apneic episodes simulates the ischemic/hypoxic
conditioning and stimulates the adaptive responses responsible for
the neuroprotection.10,11 Similarly, patients with PVD and chronic
limb hypoperfusion can provide neuroprotection against ischemic
stroke through a concept called remote ischemic preconditioning.16
It is difficult to exclude the effects of these clinical conditions on the
severity of ischemic stroke in our study because of the relatively
small sample size.
Transient ischemic attack is a process which naturally correlates
well with ischemic preconditioning. Few articles suggest that
history of TIA is associated with the poor outcomes in ischemic
stroke patients presented that (1) silent infarcts or TIAs did not
influence the long-term outcomes or mortality of ischemic stroke
patients,28,29 (2) the concept of ischemic preconditioning may be
lost in elderly patients due to the age-related loss of endogenous
mechanisms protecting against cerebral ischemia,19,22 and (3)
history of TIA is associated with a poor functional outcome at 3
months and the atherothrombotic stroke and vascular risk factors
were higher in the TIA group compared with patients without TIA.17
Articles supporting the role of TIA in ischemic preconditioning
have shown that (1) previous ipsilateral TIAs with subsequent
anterior circulation stroke present with less stroke severity and have
better functional outcomes,15 (2) the duration of TIA and the timing
of the subsequent stroke may have an impact on prognosis15,18,22
although this was not supported by Weber et al.,13 (3) previous TIA
in the same vascular territory of the current stroke may have better
prognosis,23 (4) have a protective role in lacunar19 and nonlacunar
ischemic strokes,12 (5) lower stroke severity at presentation,13 and
(6) preceding TIA was associated with reduced hospitality case
fatality rate.25 Although controversial evidence exists in reference
to the protective effects of TIA on the ischemic stroke, it has been
shown that TIA is protective if it is recent, occurred multiple times
with a shorter duration.
The results from our study do not completely rule out the
protective effects of ischemic conditioning in the ischemic stroke
patients, because the outcome after AIS depends on several
factors, including (1) acuity vs chronicity of the TIA; (2) latency of
TIA to the successive stroke, number of TIAs before the stroke, side,
vascular territory, and severity of the previous TIA; (3) etiology of the
stroke; and (4) treatments provided for the TIA and the subsequent
infarction.
Limitations of our study include (1) the fact that this is a
single-center study; (2) retrospective data collection; (3) relatively
small sample size and possible selection bias, so that the study is

likely underpowered to evaluate clinically important associations
between all hypoxic/ischemic conditions with the neurologic
outcomes; (4) could not retrieve the information regarding anterior
vs posterior TIA and their treatment with antiplatelet medications;
and (5) classification of the outcomes with mRS (0–3)30,31 was based
on the functional independence although many agree that mRS
(0–2) better reflects the reality of the good outcome. The poor
outcome trend in our patient group may be related to our previous
selection criteria for the procedure. Nevertheless, prophylactic
measures should be taken to mitigate or prevent risk factors after
the occurrence of TIA, in an attempt to reduce the risk of subsequent
ischemic stroke.

C o n c lu s i o n
Our data suggest that history of previous TIA and higher NIHSS score
at presentation are predictors of the poor outcomes at discharge in
patients with AIS. Despite the significant limitations of this study,
measures should be taken to minimize the risk factors after TIA in
an attempt to reduce the risk of subsequent stroke.
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